Why is this combination more effective than either peptide alone?

CJC-1295 (GHRH receptor/Gs/cAMP) and Ipamorelin (GHS-R1a/Gq/Ca2+) use completely different second messenger systems that independently amplify GH release. When both receptors are activated simultaneously, the two signals converge on somatotroph GH secretion in a synergistic (greater than additive) fashion. Research shows 3-5x greater GH pulse amplitude with the combination vs either compound alone.

Can both peptides be mixed in the same syringe?

Yes - both peptides are stable in the same solution and can be drawn from their respective vials into one syringe for a single injection. Reconstitute each vial separately first, then draw the desired volumes into the injection syringe.

What is the best time to administer this combination?

Protocols typically administer immediately before sleep (to amplify the natural nocturnal GH surge) or first thing in the morning in a fasted state. Elevated blood glucose and insulin suppress GH release via somatostatin feedback, so fasted administration maximises the GH response.

Bestseller

CJC-1295 + Ipamorelin Combo

Name: CJC-1295 + Ipamorelin Combo
Price: 105 USD
Availability: InStock

The gold-standard GH secretagogue combination - CJC-1295 (GHRH receptor) and Ipamorelin (ghrelin receptor) producing synergistic, pulsatile GH release 3-5x

GH BoostAnti-AgingHormonal

● In Stock

Select Variant

Quantity (vials)

Buy more, save more

—

1+ vials

−5%

3+ vials

−10%

5+ vials

−20%

10+ vials

Total Price

$105

For research & laboratory use only. Not for human consumption.

Half-Life

CJC-1295 no DAC: ~30min; Ipamorelin: ~2h

Administration Route

Subcutaneous injection

Optimised GH Stack

GHRH + GHRP combination produces 10x more GH than either alone

Lean Mass + Fat Loss

GH pulse drives IGF-1 synthesis and simultaneous lipolysis

Anti-Aging Protocol

Most widely studied peptide combination for GH restoration

Effect Profile

Based on primary research mechanisms

Combined Efficacy

Synergistic Action

Protocol Coverage

Value

Effect Timeline

Start

Sleep quality dramatically improves within first week

Week 4

Body composition shifts; recovery between sessions faster

Week 8

Visible lean mass gain; fat loss around midsection

Week 16

Peak GH/IGF-1 optimisation; significant physique change

Start — Week 1

Sleep quality dramatically improves within first week

Week 4

Body composition shifts; recovery between sessions faster

Week 8

Visible lean mass gain; fat loss around midsection

Week 16

Peak GH/IGF-1 optimisation; significant physique change

Mechanism of Action

CJC-1295 without DAC binds pituitary GHRH receptors (Gs-coupled), increasing cAMP to prime somatotrophs for GH release. Ipamorelin simultaneously binds ghrelin receptors (GHS-R1a, Gq-coupled), raising intracellular Ca2+ to trigger GH secretory granule exocytosis. Two independent receptor pathways converging on the same pituitary cell produces synergistic GH release substantially greater than either peptide alone, while maintaining physiological pulsatile patterns.

Product FAQs

Stacks Well With

IGF-1 LR3

Long-acting IGF-1 analogue with 3x longer half-life than native IGF-1, driving satellite cell activation, nitrogen retention, and protein synthesis for maximal